Concepts (206)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pseudoxanthoma Elasticum | 23 | 2021 | 28 | 5.370 |
Why?
|
| Multidrug Resistance-Associated Proteins | 24 | 2021 | 42 | 5.020 |
Why?
|
| ATP-Binding Cassette Transporters | 16 | 2021 | 82 | 2.970 |
Why?
|
| Calcinosis | 11 | 2021 | 56 | 2.940 |
Why?
|
| Liver | 8 | 2018 | 447 | 1.610 |
Why?
|
| Pyrophosphatases | 4 | 2021 | 7 | 1.130 |
Why?
|
| Diphosphates | 4 | 2021 | 7 | 1.020 |
Why?
|
| Mutation | 7 | 2017 | 1023 | 0.870 |
Why?
|
| Calcification, Physiologic | 1 | 2021 | 13 | 0.810 |
Why?
|
| Mice | 21 | 2021 | 5668 | 0.780 |
Why?
|
| Dyslipidemias | 1 | 2021 | 42 | 0.770 |
Why?
|
| Atherosclerosis | 1 | 2021 | 131 | 0.710 |
Why?
|
| Mice, Inbred C57BL | 11 | 2021 | 1530 | 0.700 |
Why?
|
| Dietary Supplements | 2 | 2018 | 196 | 0.680 |
Why?
|
| beta-Thalassemia | 2 | 2011 | 7 | 0.640 |
Why?
|
| Phenylbutyrates | 2 | 2016 | 5 | 0.630 |
Why?
|
| Animals | 25 | 2021 | 14307 | 0.600 |
Why?
|
| Disease Models, Animal | 9 | 2020 | 1300 | 0.560 |
Why?
|
| Mice, Knockout | 8 | 2020 | 897 | 0.490 |
Why?
|
| Heart Injuries | 1 | 2014 | 11 | 0.480 |
Why?
|
| Phosphoric Diester Hydrolases | 3 | 2021 | 19 | 0.440 |
Why?
|
| Vitamin K | 1 | 2011 | 6 | 0.410 |
Why?
|
| Promoter Regions, Genetic | 3 | 2011 | 484 | 0.390 |
Why?
|
| Phenotype | 6 | 2017 | 650 | 0.390 |
Why?
|
| Transcriptional Activation | 2 | 2006 | 164 | 0.350 |
Why?
|
| 5'-Nucleotidase | 3 | 2021 | 7 | 0.350 |
Why?
|
| Down-Regulation | 1 | 2011 | 420 | 0.340 |
Why?
|
| Kidney | 2 | 2011 | 322 | 0.330 |
Why?
|
| Humans | 27 | 2021 | 34853 | 0.330 |
Why?
|
| Etidronic Acid | 2 | 2018 | 3 | 0.320 |
Why?
|
| Female | 19 | 2021 | 19873 | 0.320 |
Why?
|
| Male | 17 | 2021 | 18870 | 0.310 |
Why?
|
| NF-E2 Transcription Factor, p45 Subunit | 1 | 2006 | 1 | 0.300 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2006 | 5 | 0.290 |
Why?
|
| Sp1 Transcription Factor | 1 | 2006 | 44 | 0.290 |
Why?
|
| Immunohistochemistry | 4 | 2018 | 859 | 0.290 |
Why?
|
| Elastin | 1 | 2006 | 37 | 0.280 |
Why?
|
| Macrophages | 2 | 2021 | 431 | 0.280 |
Why?
|
| Blood Proteins | 1 | 2006 | 65 | 0.280 |
Why?
|
| Mutation, Missense | 3 | 2016 | 80 | 0.270 |
Why?
|
| Cell Membrane | 4 | 2016 | 360 | 0.260 |
Why?
|
| Osteogenesis | 2 | 2020 | 31 | 0.230 |
Why?
|
| Arteries | 2 | 2014 | 67 | 0.220 |
Why?
|
| Biopsy, Needle | 2 | 2018 | 60 | 0.210 |
Why?
|
| Joint Diseases | 1 | 2021 | 3 | 0.200 |
Why?
|
| Adenosine Triphosphate | 2 | 2018 | 180 | 0.200 |
Why?
|
| Bile Acids and Salts | 1 | 2021 | 31 | 0.200 |
Why?
|
| Vascular Diseases | 1 | 2021 | 30 | 0.200 |
Why?
|
| Blotting, Western | 3 | 2014 | 834 | 0.200 |
Why?
|
| Osteoblasts | 1 | 2020 | 33 | 0.200 |
Why?
|
| Risk Assessment | 3 | 2018 | 727 | 0.190 |
Why?
|
| Bone and Bones | 1 | 2020 | 89 | 0.190 |
Why?
|
| Organ Specificity | 3 | 2011 | 123 | 0.180 |
Why?
|
| Cholesterol | 1 | 2020 | 194 | 0.170 |
Why?
|
| Insulin Resistance | 1 | 2020 | 177 | 0.170 |
Why?
|
| Kidney Calculi | 1 | 2018 | 6 | 0.170 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2020 | 224 | 0.170 |
Why?
|
| Cell Aggregation | 1 | 2018 | 14 | 0.170 |
Why?
|
| Random Allocation | 1 | 2018 | 139 | 0.170 |
Why?
|
| Mitochondria | 2 | 2020 | 454 | 0.160 |
Why?
|
| Alleles | 2 | 2016 | 284 | 0.160 |
Why?
|
| Adenosine Diphosphate | 1 | 2018 | 17 | 0.160 |
Why?
|
| Bone Density Conservation Agents | 1 | 2018 | 22 | 0.160 |
Why?
|
| Species Specificity | 1 | 2018 | 233 | 0.160 |
Why?
|
| Retrospective Studies | 2 | 2021 | 1961 | 0.160 |
Why?
|
| Transgenes | 1 | 2017 | 57 | 0.150 |
Why?
|
| Acute Disease | 1 | 2017 | 141 | 0.150 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2017 | 109 | 0.150 |
Why?
|
| Adenosine | 2 | 2018 | 54 | 0.140 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2010 | 528 | 0.140 |
Why?
|
| Myocardium | 2 | 2017 | 224 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2017 | 984 | 0.130 |
Why?
|
| Aorta | 2 | 2018 | 161 | 0.130 |
Why?
|
| Stroke | 1 | 2018 | 274 | 0.130 |
Why?
|
| Treatment Outcome | 1 | 2018 | 1349 | 0.130 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2013 | 185 | 0.120 |
Why?
|
| Minerals | 1 | 2014 | 45 | 0.120 |
Why?
|
| Cells, Cultured | 3 | 2020 | 1442 | 0.120 |
Why?
|
| Osteopontin | 1 | 2014 | 35 | 0.120 |
Why?
|
| Chronic Disease | 1 | 2017 | 469 | 0.120 |
Why?
|
| Rats | 1 | 2021 | 3261 | 0.120 |
Why?
|
| Calcium-Binding Proteins | 1 | 2014 | 72 | 0.120 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2014 | 68 | 0.120 |
Why?
|
| Myocardial Ischemia | 1 | 2014 | 72 | 0.110 |
Why?
|
| Biological Transport | 2 | 2011 | 175 | 0.110 |
Why?
|
| Hepatocytes | 1 | 2013 | 74 | 0.110 |
Why?
|
| Connective Tissue | 2 | 2017 | 9 | 0.110 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 628 | 0.100 |
Why?
|
| Ankle Brachial Index | 1 | 2011 | 16 | 0.100 |
Why?
|
| Carotid Arteries | 1 | 2011 | 29 | 0.100 |
Why?
|
| Treatment Failure | 1 | 2011 | 65 | 0.100 |
Why?
|
| Case-Control Studies | 3 | 2020 | 1056 | 0.100 |
Why?
|
| INDEL Mutation | 1 | 2010 | 4 | 0.090 |
Why?
|
| Genomic Instability | 1 | 2010 | 34 | 0.090 |
Why?
|
| Cell Line | 3 | 2013 | 1289 | 0.090 |
Why?
|
| Mice, Transgenic | 1 | 2011 | 608 | 0.090 |
Why?
|
| Adult | 7 | 2020 | 11034 | 0.090 |
Why?
|
| Middle Aged | 7 | 2018 | 9642 | 0.090 |
Why?
|
| Cohort Studies | 3 | 2018 | 1422 | 0.080 |
Why?
|
| DNA, Complementary | 2 | 2006 | 175 | 0.080 |
Why?
|
| RNA, Messenger | 2 | 2011 | 1152 | 0.080 |
Why?
|
| DNA Mutational Analysis | 2 | 2010 | 89 | 0.080 |
Why?
|
| Heterozygote | 1 | 2008 | 91 | 0.080 |
Why?
|
| Pedigree | 2 | 2008 | 64 | 0.080 |
Why?
|
| Skull | 2 | 2020 | 35 | 0.080 |
Why?
|
| Tissue Distribution | 1 | 2006 | 197 | 0.070 |
Why?
|
| Elastic Tissue | 1 | 2006 | 7 | 0.070 |
Why?
|
| Tropoelastin | 1 | 2006 | 13 | 0.070 |
Why?
|
| Aged | 5 | 2018 | 6448 | 0.070 |
Why?
|
| Muscle, Smooth | 1 | 2006 | 51 | 0.070 |
Why?
|
| Molecular Sequence Data | 2 | 2006 | 1490 | 0.070 |
Why?
|
| Transcription Factors | 1 | 2011 | 653 | 0.070 |
Why?
|
| Cardiovascular System | 1 | 2006 | 30 | 0.070 |
Why?
|
| Cloning, Molecular | 1 | 2006 | 310 | 0.070 |
Why?
|
| Metabolic Diseases | 1 | 2006 | 32 | 0.070 |
Why?
|
| Eye | 1 | 2006 | 68 | 0.070 |
Why?
|
| Signal Transduction | 1 | 2014 | 1802 | 0.070 |
Why?
|
| Skin | 1 | 2006 | 173 | 0.060 |
Why?
|
| Base Sequence | 1 | 2006 | 932 | 0.060 |
Why?
|
| Fibroblasts | 1 | 2006 | 252 | 0.060 |
Why?
|
| DNA Methylation | 1 | 2006 | 301 | 0.060 |
Why?
|
| Haplotypes | 1 | 2003 | 152 | 0.060 |
Why?
|
| Ultrasonography | 2 | 2013 | 115 | 0.050 |
Why?
|
| Osteocalcin | 1 | 2020 | 4 | 0.050 |
Why?
|
| Genotype | 1 | 2003 | 641 | 0.050 |
Why?
|
| Tibia | 1 | 2020 | 18 | 0.050 |
Why?
|
| Femur | 1 | 2020 | 35 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2006 | 968 | 0.050 |
Why?
|
| Lipase | 1 | 2020 | 16 | 0.050 |
Why?
|
| France | 2 | 2011 | 17 | 0.050 |
Why?
|
| Activin Receptors, Type I | 1 | 2018 | 4 | 0.040 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2018 | 7 | 0.040 |
Why?
|
| Insulin | 1 | 2020 | 224 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2020 | 333 | 0.040 |
Why?
|
| Young Adult | 2 | 2020 | 4012 | 0.040 |
Why?
|
| Urinalysis | 1 | 2018 | 31 | 0.040 |
Why?
|
| Mice, Inbred C3H | 1 | 2018 | 83 | 0.040 |
Why?
|
| Child | 1 | 2006 | 2875 | 0.040 |
Why?
|
| Neovascularization, Physiologic | 1 | 2018 | 70 | 0.040 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2018 | 53 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2018 | 157 | 0.040 |
Why?
|
| Phosphates | 1 | 2017 | 49 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2020 | 628 | 0.040 |
Why?
|
| Sex Factors | 1 | 2020 | 859 | 0.040 |
Why?
|
| Risk Factors | 2 | 2018 | 3414 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 206 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2017 | 212 | 0.040 |
Why?
|
| Cognition | 1 | 2020 | 373 | 0.040 |
Why?
|
| Prognosis | 1 | 2018 | 707 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2011 | 1353 | 0.030 |
Why?
|
| Incidence | 1 | 2018 | 882 | 0.030 |
Why?
|
| Calcium | 1 | 2017 | 445 | 0.030 |
Why?
|
| Heart Valves | 1 | 2013 | 2 | 0.030 |
Why?
|
| Ventricular Function | 1 | 2013 | 8 | 0.030 |
Why?
|
| Diastole | 1 | 2013 | 46 | 0.030 |
Why?
|
| Systole | 1 | 2013 | 65 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2014 | 111 | 0.030 |
Why?
|
| Dogs | 1 | 2013 | 138 | 0.030 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2013 | 27 | 0.030 |
Why?
|
| Organ Size | 1 | 2013 | 148 | 0.030 |
Why?
|
| Cell Polarity | 1 | 2013 | 53 | 0.030 |
Why?
|
| Protein Folding | 1 | 2013 | 121 | 0.030 |
Why?
|
| Fibrosis | 1 | 2013 | 146 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2013 | 350 | 0.030 |
Why?
|
| Zebrafish | 1 | 2013 | 118 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 2013 | 101 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 2333 | 0.030 |
Why?
|
| Pregnancy | 1 | 2017 | 1503 | 0.030 |
Why?
|
| X-Ray Microtomography | 1 | 2012 | 12 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2012 | 117 | 0.030 |
Why?
|
| Vibrissae | 1 | 2012 | 29 | 0.030 |
Why?
|
| Colorimetry | 1 | 2012 | 40 | 0.030 |
Why?
|
| Coronary Artery Disease | 1 | 2013 | 147 | 0.030 |
Why?
|
| Compliance | 1 | 2011 | 9 | 0.030 |
Why?
|
| Pulsatile Flow | 1 | 2011 | 15 | 0.030 |
Why?
|
| Regional Blood Flow | 1 | 2011 | 47 | 0.030 |
Why?
|
| Hospitals, University | 1 | 2011 | 38 | 0.030 |
Why?
|
| Cardiomyopathies | 1 | 2012 | 55 | 0.030 |
Why?
|
| Myocytes, Cardiac | 1 | 2013 | 165 | 0.030 |
Why?
|
| Body Weight | 1 | 2013 | 404 | 0.030 |
Why?
|
| Apoptosis | 1 | 2018 | 1317 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 213 | 0.020 |
Why?
|
| Linear Models | 1 | 2011 | 253 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2010 | 17 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2011 | 424 | 0.020 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2010 | 28 | 0.020 |
Why?
|
| Exons | 1 | 2010 | 80 | 0.020 |
Why?
|
| Disease Progression | 1 | 2012 | 580 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2008 | 211 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2008 | 430 | 0.020 |
Why?
|
| DNA | 1 | 2008 | 549 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2011 | 2561 | 0.010 |
Why?
|
| Ribonucleases | 1 | 2003 | 29 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2003 | 125 | 0.010 |
Why?
|
| Rabbits | 1 | 2003 | 278 | 0.010 |
Why?
|
| Nucleotides | 1 | 2002 | 33 | 0.010 |
Why?
|
| Gene Library | 1 | 2002 | 55 | 0.010 |
Why?
|
| Adenosine Triphosphatases | 1 | 2002 | 78 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 605 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2002 | 123 | 0.010 |
Why?
|
| Glutathione | 1 | 2002 | 160 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2003 | 1124 | 0.010 |
Why?
|
| Kinetics | 1 | 2002 | 650 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2002 | 550 | 0.010 |
Why?
|
| Protein Binding | 1 | 2002 | 913 | 0.010 |
Why?
|
| Time Factors | 1 | 2002 | 1681 | 0.010 |
Why?
|